Approval · Notice of Compliance 974 · 2000
EMINASE: Notice of Compliance 974
Issued March 30, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 974
- Date
- March 30, 2000
- Company
- Shire Canada IncLaval, QC, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Fibrinolytic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EMINASE | 02229390 | Cancelled Post Market |
Medicinal ingredients
- APSAC 30 UNIT per 5ML